• Cixutumumab
    Cixutumumab (IMC-A12) is a human monoclonal antibody for the treatment of solid tumors. This drug was developed by ImClone Systems, since acquired by...
    6 KB (617 words) - 14:25, 9 May 2024
  • Thumbnail for Dexamethasone
    Dexamethasone
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    68 KB (5,993 words) - 00:22, 20 June 2024
  • Thumbnail for Erythropoietin
    Erythropoietin
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    31 KB (3,413 words) - 23:30, 21 June 2024
  • Thumbnail for Amitriptyline
    Amitriptyline
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    92 KB (8,667 words) - 19:29, 28 June 2024
  • Thumbnail for Osimertinib
    Osimertinib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    17 KB (1,489 words) - 05:47, 7 April 2024
  • Thumbnail for Insulin
    Insulin
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    121 KB (13,799 words) - 06:42, 1 July 2024
  • Thumbnail for Fruquintinib
    Fruquintinib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    10 KB (579 words) - 06:46, 26 June 2024
  • Thumbnail for Repotrectinib
    Repotrectinib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    10 KB (661 words) - 04:10, 26 June 2024
  • Thumbnail for Dehydroepiandrosterone
    Dehydroepiandrosterone
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    42 KB (3,935 words) - 04:01, 30 April 2024
  • Thumbnail for List of therapeutic monoclonal antibodies
    List of therapeutic monoclonal antibodies
    Citatuzumab bogatox Fab humanized EpCAM ovarian cancer and other solid tumors Cixutumumab mab human IGF-1 receptor (CD221) solid tumors Clazakizumab mab humanized...
    135 KB (4,054 words) - 22:35, 2 July 2024
  • Thumbnail for Insulin-like growth factor 1
    Insulin-like growth factor 1
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    36 KB (4,822 words) - 06:03, 26 June 2024
  • Cerebrolysin
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    12 KB (1,049 words) - 10:54, 12 January 2024
  • Anti-VEGF
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    14 KB (1,671 words) - 12:47, 23 April 2024
  • Neurotrophic factors
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    16 KB (1,784 words) - 04:08, 6 January 2024
  • Thumbnail for Nintedanib
    Nintedanib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    34 KB (3,010 words) - 05:48, 22 May 2024
  • Thumbnail for Cetuximab
    Cetuximab
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    26 KB (2,542 words) - 19:54, 20 March 2024
  • IGF-1 LR3
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    5 KB (412 words) - 23:17, 19 June 2023
  • Bevacizumab
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    74 KB (6,565 words) - 05:35, 13 June 2024
  • Amivantamab
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    23 KB (1,755 words) - 04:41, 3 July 2024
  • Thumbnail for Pertuzumab
    Pertuzumab
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    22 KB (2,133 words) - 06:05, 5 July 2024
  • Thumbnail for Faricimab
    Faricimab
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    20 KB (1,543 words) - 06:38, 10 March 2024
  • Thumbnail for Testosterone
    Testosterone
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    150 KB (15,741 words) - 10:52, 27 June 2024
  • Thumbnail for Filgrastim
    Filgrastim
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    24 KB (1,700 words) - 04:21, 2 July 2024
  • Thumbnail for HER2
    HER2
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    43 KB (4,776 words) - 13:06, 5 July 2024
  • Vascular endothelial growth factor
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    40 KB (4,580 words) - 05:24, 3 June 2024
  • Thumbnail for Testosterone (medication)
    Testosterone (medication)
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    110 KB (10,699 words) - 12:57, 17 June 2024
  • Thumbnail for Tyrosine kinase inhibitor
    Tyrosine kinase inhibitor
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    9 KB (1,081 words) - 04:46, 16 June 2022
  • Thumbnail for Neurotrophin
    Neurotrophin
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    27 KB (3,071 words) - 04:54, 3 June 2024
  • Thumbnail for Nerve growth factor
    Nerve growth factor
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    23 KB (2,786 words) - 23:53, 26 April 2024
  • Thumbnail for Alectinib
    Alectinib
    BMS-754807 Linsitinib NVP-ADW742 NVP-AEW541 OSl-906 Antibodies: AVE-1642 Cixutumumab Dalotuzumab Figitumumab Ganitumab Robatumumab R1507 Teprotumumab Xentuzumab...
    22 KB (1,787 words) - 05:10, 1 July 2024